Search research articles
Contact Us
Filters
Showing results (141-150 of 163) with videos related to
Page
of 17
Sort By:
Brain Research
|
July 31, 1995
Effects of systemic and local ethanol on responses of rat cerebellar Purkinje neurons to iontophoretically applied norepinephrine and gamma-aminobutyric acid
R S Lee, S S Smith, J K Chapin, et al.
Biological Psychiatry
|
September 6, 2011
Differential sensitivity to psychostimulants across prefrontal cognitive tasks: differential involvement of noradrenergic α₁ - and α₂-receptors
Craig W Berridge, Jed S Shumsky, Matt E Andrzejewski, et al.
Anatomical Record (Hoboken, N.J. : 2007)
|
September 9, 2011
Experimental strategies for investigating psychostimulant drug actions and prefrontal cortical function in ADHD and related attention disorders
Kara L Agster, Brian D Clark, Wen-Jun Gao, et al.
Cell Reports Methods
|
April 3, 2024
Droplet-based proteomics reveals CD36 as a marker for progenitors in mammary basal epithelium
Matthew Waas, Amanda Khoo, Pirashaanthy Tharmapalan, et al.
Blood Advances
|
September 9, 2021
Abnormal B-cell development in TIMP-deficient bone marrow
Ashley Weiss, Sanjay Saw, Alison Aiken, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 30, 2005
Randomized phase III trial comparing cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer
C P Belani, J S Lee, M A Socinski, et al.
Antimicrobial Agents and Chemotherapy
|
August 7, 2015
Pharmacokinetics of Antituberculosis Drugs in HIV-Positive and HIV-Negative Adults in Malawi
J J van Oosterhout, F K Dzinjalamala, A Dimba, et al.
Neuropharmacology
|
January 12, 2019
Selective activation of Dopamine D3 receptors and norepinephrine transporter blockade enhances sustained attention
Courtney A Marshall, Zachary D Brodnik, Ole V Mortensen, et al.
Experimental Neurology
|
November 3, 2020
A novel dopamine D3R agonist SK609 with norepinephrine transporter inhibition promotes improvement in cognitive task performance in rodent and non-human primate models of Parkinson's disease
Jay S Schneider, Courtney A Marshall, Lauren Keibel, et al.
Clinical Pharmacology and Therapeutics
|
February 5, 2017
Suboptimal Exposure to Anti-TB Drugs in a TBM/HIV+ Population Is Not Related to Antiretroviral Therapy
M E Török, G Aljayyoussi, D Waterhouse, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 163) with videos related to
Sort By:
Page
of 17
Brain Research
|
July 31, 1995
Effects of systemic and local ethanol on responses of rat cerebellar Purkinje neurons to iontophoretically applied norepinephrine and gamma-aminobutyric acid
R S Lee, S S Smith, J K Chapin, et al.
Biological Psychiatry
|
September 6, 2011
Differential sensitivity to psychostimulants across prefrontal cognitive tasks: differential involvement of noradrenergic α₁ - and α₂-receptors
Craig W Berridge, Jed S Shumsky, Matt E Andrzejewski, et al.
Anatomical Record (Hoboken, N.J. : 2007)
|
September 9, 2011
Experimental strategies for investigating psychostimulant drug actions and prefrontal cortical function in ADHD and related attention disorders
Kara L Agster, Brian D Clark, Wen-Jun Gao, et al.
Cell Reports Methods
|
April 3, 2024
Droplet-based proteomics reveals CD36 as a marker for progenitors in mammary basal epithelium
Matthew Waas, Amanda Khoo, Pirashaanthy Tharmapalan, et al.
Blood Advances
|
September 9, 2021
Abnormal B-cell development in TIMP-deficient bone marrow
Ashley Weiss, Sanjay Saw, Alison Aiken, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 30, 2005
Randomized phase III trial comparing cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer
C P Belani, J S Lee, M A Socinski, et al.
Antimicrobial Agents and Chemotherapy
|
August 7, 2015
Pharmacokinetics of Antituberculosis Drugs in HIV-Positive and HIV-Negative Adults in Malawi
J J van Oosterhout, F K Dzinjalamala, A Dimba, et al.
Neuropharmacology
|
January 12, 2019
Selective activation of Dopamine D3 receptors and norepinephrine transporter blockade enhances sustained attention
Courtney A Marshall, Zachary D Brodnik, Ole V Mortensen, et al.
Experimental Neurology
|
November 3, 2020
A novel dopamine D3R agonist SK609 with norepinephrine transporter inhibition promotes improvement in cognitive task performance in rodent and non-human primate models of Parkinson's disease
Jay S Schneider, Courtney A Marshall, Lauren Keibel, et al.
Clinical Pharmacology and Therapeutics
|
February 5, 2017
Suboptimal Exposure to Anti-TB Drugs in a TBM/HIV+ Population Is Not Related to Antiretroviral Therapy
M E Török, G Aljayyoussi, D Waterhouse, et al.
Page
of 17